In addition to its chemosensitizing effects, AMD3100 synergistically interacts with antibodies targeting PD‐L1 and CTLA‐4 results in enhanced T‐cell infiltration into tumor tissues, yielding a greater anticancer response.340. This evidence concerns the gene CTLA4 and neoplasm.